Covetrus Announces First-Ever Chief Consumer Officer

$CVET
Other Pharmaceuticals
Health Care
Get the next $CVET alert in real time by email

PORTLAND, Maine--()--Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Deborah Sharkey as chief consumer officer (CCO). In this first-of-its-kind role for the company, Deborah will be responsible for developing innovative solutions that support and strengthen the relationship between veterinarian and pet owner.

“Like all modern consumers, pet owners desire convenience coupled with seamless delivery of products and services,” said Ben Wolin, Covetrus president and CEO. “With her dual background in e-commerce and consumer experience, Deborah will be instrumental in our mission to empower veterinarians to drive better health outcomes for animals, as well as helping extend veterinarians’ care beyond the walls of their practices.”

As CCO, Deborah Sharkey oversees marketing, product and strategy for the consumer group within Covetrus’ Global Technology Services which also encompasses the SmartPak brand.

“I am excited to join the largest global animal health company dedicated to veterinarians,” said Deborah Sharkey. “As an animal lover, my veterinarian is a family hero, and I am looking forward to applying my consumer expertise to this industry. With our technology, Covetrus is uniquely positioned to help veterinarians improve access to animal healthcare for pet owners and their beloved pets.”

Deborah brings extensive global e-commerce experience across both large tech company and startup environments, with a particular expertise in multi-customer marketplaces. Previously Deborah ran eBay’s Australia business and was its vice president of local marketplaces. She was also chief operating officer at DogVacay, which was acquired by Rover.com.

Covetrus will be participating in the 2021 Animal Health Innovation Europe forum taking place virtually on February 22 and 23. Deborah will be a panelist, along with other industry leaders addressing the timely topic of The Future of Pet Care Delivery in a Post Covid World. She will speak to Covetrus’ support of veterinary care today and into the future.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,500 employees serving over 100,000 customers around the globe. For more information about Covetrus visit https://covetrus.com/.

Get the next $CVET alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CVET

DatePrice TargetRatingAnalyst
6/13/2022$22.00Buy → Hold
Stifel
5/23/2022Outperform → Mkt Perform
Raymond James
11/18/2021$19.00Equal-Weight
Morgan Stanley
11/5/2021$37.00 → $27.00Outperform
Raymond James
8/9/2021$46.00 → $38.00Overweight
Barclays
8/6/2021$38.00 → $37.00Outperform
Raymond James
8/5/2021$29.00Neutral
Credit Suisse
7/12/2021$30.00Neutral → Buy
Guggenheim
More analyst ratings

$CVET
Press Releases

Fastest customizable press release news feed in the world

See more
  • Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer

    Semrush (NYSE:SEMR), a leading online visibility management SaaS platform, is pleased to announce that Veronique Montreuil joins the executive team as Chief Customer and Data Officer. With over 20 years of experience in customer success and customer experience, Veronique brings a wealth of expertise to enhance customer relationships and drive growth. In her most recent role as Head of Technology Sales and Customer Success at Covetrus (NASDAQ:CVET), Veronique led a team of 275 professionals, driving operational efficiency, fostering deep customer relationships, and optimizing customer value through strategic initiatives and process improvements. She held prior roles at companies INAP (NASD

    $SEMR
    $CVET
    Computer Software: Prepackaged Software
    Technology
    Other Pharmaceuticals
    Health Care
  • Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600

    NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18. Clayton, Dubilier & Rice and TPG Capital acquired Covetrus in a deal that closed today. MillerKnoll is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector October 18, 2022 S&P MidCap 400 Addition Westlake WLK Materials S&P MidCap 400 Deletion Miller

    $CVET
    $MLKN
    $SPGI
    $WLK
    Other Pharmaceuticals
    Health Care
    Office Equipment/Supplies/Services
    Consumer Discretionary
  • Covetrus Names Michelle Bonfilio as Chief People Officer

    Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220926005710/en/Michelle Bonfilio (Photo: Business Wire) "Michelle has a proven track record of empowering teams to achieve results, driving an inclusive culture and aligning purpose to the work employees do each day," sai

    $CVET
    Other Pharmaceuticals
    Health Care

$CVET
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CVET
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CVET
SEC Filings

See more

$CVET
Leadership Updates

Live Leadership Updates

See more
  • Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer

    Semrush (NYSE:SEMR), a leading online visibility management SaaS platform, is pleased to announce that Veronique Montreuil joins the executive team as Chief Customer and Data Officer. With over 20 years of experience in customer success and customer experience, Veronique brings a wealth of expertise to enhance customer relationships and drive growth. In her most recent role as Head of Technology Sales and Customer Success at Covetrus (NASDAQ:CVET), Veronique led a team of 275 professionals, driving operational efficiency, fostering deep customer relationships, and optimizing customer value through strategic initiatives and process improvements. She held prior roles at companies INAP (NASD

    $SEMR
    $CVET
    Computer Software: Prepackaged Software
    Technology
    Other Pharmaceuticals
    Health Care
  • Covetrus Names Michelle Bonfilio as Chief People Officer

    Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220926005710/en/Michelle Bonfilio (Photo: Business Wire) "Michelle has a proven track record of empowering teams to achieve results, driving an inclusive culture and aligning purpose to the work employees do each day," sai

    $CVET
    Other Pharmaceuticals
    Health Care
  • Covetrus Names Margie B. Pritchard General Counsel

    Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus. Prior to being named as General Counsel, Pritchard most recently served as Vice President, Deputy Counsel at Covetrus, where she was responsible for corporate and board governance, public reporting, advising investor relations, employment matters including compensation, and providing general legal counsel to executive management. "Margie has been serving as Interim General Counsel since December 2021, and we are thrilled to have h

    $CVET
    Other Pharmaceuticals
    Health Care

$CVET
Financials

Live finance-specific insights

See more
  • Covetrus Announces Financial Results for Second Quarter of 2022

    Second quarter 2022 net sales of $1.22 billion, an increase of 2% year-over-year; GAAP net loss attributable to Covetrus of $(4) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA was flat year-over-year at $66 million, including a $2 million year-over-year headwind from the strengthening of the U.S. Dollar First half 2022 net sales of $2.37 billion, an increase of 3% year-over-year; GAAP net loss attributable to Covetrus of $(6) million Non-GAAP organic net sales growth of 6% year-over-year Non-GAAP adjusted EBITDA increased 5% year-over-year to $129 million, including a $4 million year-over-year headwind from the strengthening of the U.S.

    $CVET
    Other Pharmaceuticals
    Health Care
  • Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information

    Covetrus® (NASDAQ:CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2022 results after the market closes on Thursday, May 5, 2022. Following the release, the Company will hold a conference call at 4:30 PM ET, during which Ben Wolin, president and chief executive officer, and Matthew Foulston, executive vice president and chief financial officer, will review the results. To access the live webcast of the conference call and the corresponding slide presentation, individuals can register at our Investor Relations site: https://ir.covetrus.com/investors/events-and-presentations. An archived edition of the conference call will be

    $CVET
    Other Pharmaceuticals
    Health Care
  • Covetrus Announces Financial Results for Fourth Quarter and Full-Year of 2021

    Fourth quarter 2021 net sales of $1.12 billion, unchanged year-over-year; GAAP net loss attributable to Covetrus of $(3) million Non-GAAP organic net sales growth of 2% year-over-year Non-GAAP adjusted EBITDA increased 13% year-over-year to $63 million Full-year 2021 net sales of $4.58 billion, an increase of 5% year-over-year; GAAP net loss attributable to Covetrus of $(54) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA increased 8% year-over-year to $244 million 2022 non-GAAP organic net sales growth guidance of 7% to 8% and non-GAAP adjusted EBITDA guidance in the range of $270 million to $280 million Covetrus® (NASDAQ:CVET), a

    $CVET
    Other Pharmaceuticals
    Health Care

$CVET
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more